Surgical Glue Market Size, Share, Growth, and Industry Analysis, By Type (Natural,Synthetic and Semi Synthetic), By Application (Hospitals,Ambulatory Surgical Centers,Other End Users), Regional Insights and Forecast to 2035

Surgical Glue Market Overview

The global Surgical Glue Market size is projected to grow from USD 5515.18 million in 2026 to USD 6142.81 million in 2027, reaching USD 14546.08 million by 2035, expanding at a CAGR of 11.38% during the forecast period.

The global Surgical Glue Market in 2023 was estimated at approximately USD 2,501.4 million in the surgical sealants & adhesives / surgical glue category. Natural or biological adhesives & sealants comprised about USD 1,548.9 million of that total. In 2024, global surgical glue market size is estimated at USD 2.86 billion, with natural adhesives holding about 59.51% of the market and synthetic & semi‑synthetic adhesives the remainder. Focusing on the USA Surgical Glue Market, in 2024 the USA segment of the surgical glue market was valued at about USD 331.14 million in the U.S. surgical glue market, with hospitals/clinics consuming USD 245.56 million of that. In 2023 in the U.S. surgical sealants & adhesives market natural/biological adhesives & sealants accounted for 61.5% of product share in the U.S. market.

In the USA Surgical Glue Market in 2023‑2024, hospitals/clinics accounted for approximately 74.2% of the U.S. surgical glue usage (USD 245.56 million of USD 331.14 million). Natural adhesives held about 58.9%‑61.5% of U.S. product type share in surgical sealants & adhesives, with synthetic & semi‑synthetic types forming the balance. In end‑user segmentation, hospitals dominated, followed by ambulatory surgical centers and specialty clinics. The indication segment “surgical hemostat” in 2024 represented USD 214.43 million of the U.S. surgical glue market. Cardiac surgery was the largest application in U.S., with USD 138.34 million allocated in 2024 to that category.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Increasing surgical procedure volumes contribute approximately +1.5% impact; growing preference for faster wound closure and lower infection risk adds about +1.8%; technological advances add +1.2%; incidence of road accidents adds +0.9%; adoption of robotic surgery adds +0.7%.
• Major Market Restraint: High cost of surgical glue products (price premiums around 20‑40% over sutures/staples in many markets); limited shelf life for natural adhesives (storage constraints affecting approx 30‑40% of inventory); adverse reactions & cytotoxicity issues in some synthetic glues affecting nearly 15‑25% of product complaints; reimbursement barriers in ambulatory settings (25‑30% of potential demand suppressed).
• Emerging Trends: Synthetic & semi‑synthetic adhesives rising with around 40‑45% of product pipeline innovation; ambulatory surgical centers increasing share by 9‑10% annually in many developed nations; bio‑resorbable or biodegradable adhesives growing interest in nearly 35‑40% of new product launches; cosmetic surgery adhesive formulations showing over 12% share in certain markets; Asia‑Pacific absorbing around 24‑25% of global adoption presently.
• Regional Leadership: North America holds about 39‑40% of global Surgical Glue Market share; Europe holds around 25‑30%; Asia‑Pacific approx 24%; Latin America & Middle East & Africa combined under 10%‑12% presently.
• Competitive Landscape: Hospitals control over 54‑65% of end‑user share depending on geography; ambulatory surgical centers contribute approx 20‑25%; specialty clinics and other end users share remainder (10‑20%). Natural adhesives hold 60‑62% share of product type; synthetic & semi‑synthetic 38‑40%. Cardiovascular surgery applications represent about 30‑33% of usage in many markets; general surgery approx 17‑18%.
• Market Segmentation: By product type: natural adhesives & sealants ≥ 59%; synthetic & semi‑synthetic 40‑41%; by application: cardiovascular surgery 32‑33%; general surgery 17‑18%; by end‑user: hospitals 54‑65%; ambulatory surgical centers 20‑25%; others 10‑20%.
• Recent Development: In 2024, natural adhesives & sealants held 62.2% of share in 2024 product segmentation; general surgery applications contributed 18.1% share of application segmentation in 2024; USA hospitals/clinics held about USD 245.56 million of U.S. surgical glue market in 2024; cardio surgery accounted for USD 138.34 million in U.S. in 2024; surgeons increasingly adopting synthetic adhesives with growth rates in some segments in the US up by 12‑15% year‑on‑

Surgical Glue Market Latest Trends

The Surgical Glue Market Trends show that natural adhesives & sealants remain the leading product type globally, capturing around 59‑62% of the market by share in 2024, due to clinician familiarity and safety profiles. Synthetic & semi‑synthetic adhesives are rapidly increasing in adoption, particularly in high acuity surgical specialties such as cardiovascular surgery, neurosurgery, and reconstructive applications. Cardiovascular surgery alone accounted for approximately 32.5% of global surgical glue market share in 2024. End‑user trends: hospitals still dominate, holding 54‑65% of global market share; ambulatory surgical centers are gaining ground, with share increasing by around 9‑10% annually in many developed economies. Specialty clinics also contributing around 10‑20% of usage, especially in cosmetic & ophthalmic surgery. By geography, North America commanded 39‑40% of global share in 2023‑2024; Asia‑Pacific held around 24‑25% and Europe about 25‑30%. Product formulation trends show increased preference for bio‑resorbable adhesives, fast‑setting cyanoacrylates, and hydrogel‑based adhesives in spray or patch forms; these account for a growing portion of new product development (in some pipelines over 30‑40%). The shift to outpatient procedures favors adhesives with easier handling, single dose/vial formats. Regulatory approvals in U.S. and Japan have shortened times for synthetic adhesive clearances, boosting product launches by approximately 10‑15% in those markets in recent years. Surgical Glue Market Outlook is being shaped by these trends: increased minimally invasive & robotic surgeries pushing need for precise adhesives; environmental & safety concerns pushing bio‑based natural adhesives; end‑user diversification from hospital‑dominated to more ambulatory settings.

Surgical Glue Market Dynamics

DRIVER

"Rising number of surgical procedures and demand for wound closure alternatives"

Natural adhesives hold approx 59‑62% of market share globally in 2024, which is driven by over 234 million major surgical procedures performed annually worldwide, meaning high demand for surgical glue in tissue sealing and hemostasis. Hospitals in the U.S. in 2024 used USD 245.56 million out of USD 331.14 million U.S. surgical glue market mostly for natural adhesives, part of which is due to high volume surgeries such as cardiac surgery which alone represented USD 138.34 million in 2024. Patient emphasis on wound healing with less infection risk and faster recovery is pushing preference for adhesives over sutures/staples in an estimated 20‑30% of surgical cases in markets such as North America and Europe. The synthetic segment, though smaller, is rising rapidly: in U.S., natural adhesive revenue was USD 194.94 million in 2024, synthetic segment showing fastest growth, capturing approximately 40‑41% of non‑natural share.

RESTRAINT

"High cost, regulations, and alternative products"

Natural adhesives often require cold‑chain storage, have limited shelf life (storage constraints affect 30‑40% of inventory in developing markets), and synthetic glues may exhibit cytotoxicity or adverse tissue reactions in 15‑25% of reported product issues, which restrains adoption. Regulatory pathways in many countries demand extensive testing—synthetic adhesives must circle through FDA, PMDA, or EU MDR processes, which can delay time‑to‑market by months for 20‑30% of new product filings. Availability of cheaper alternatives (sutures, staples, traditional adhesive tapes) limits premium surgical glue uptake in outpatient or non‑critical surgeries; in many low‑/mid‑income countries surgical glue usage is under 10% of closure methods for simple incisions. Reimbursement challenges: hospitals may receive capped payment for wound closure, reducing incentive to select higher cost adhesives; estimated 25‑30% of potential hospital demand is suppressed due to reimbursement or cost constraints.

OPPORTUNITY

"Innovation, market expansion and cost efficiencies"

Emerging markets (Asia‑Pacific, Latin America, Middle East & Africa) offer substantial opportunity: Asia‑Pacific holds about 24‑25% of global market share in 2024, but healthcare spending and surgical volumes are increasing, making that region fastest growing. Product innovation: hydrogels, cyanoacrylate blends, bio‑resorbable adhesives represent a rising slice of new product launches—estimated at 30‑40% of pipeline. Ambulatory surgical centers increasing share (presently 20‑25%) offer markets for simplified, cost‑efficient adhesive formats (single‑dose, sprays, patches). Applications in cosmetic, ophthalmic, urological surgeries (which together represent 15‑20% of non‑hospital end‑users in many markets) are growth segments. Cost‑reduction in synthetic glue manufacture and improved natural adhesive stabilization (e.g. fibrin / collagen preservation) may reduce price premiums by 10‑20% in future, improving adoption.

CHALLENGE

"Supply chain, safety, and product differentiation"

Supply chain for natural adhesives often depends on plasma, animal or human derived components; disruptions in supply or raw material quality affect about 20‑30% of natural adhesive suppliers. Sterilization and storage of biological adhesives impose logistic cost, notably in regions where cold chain is less reliable (affecting 15‑25% of deliveries). Synthetic adhesives risk tissue irritation, cytotoxicity, or allergic reactions; clinical trials in some jurisdictions rejected 10‑15% of synthetic glue variants due to safety concerns. Differentiating products: many adhesives perform similarly in hemostasis, so manufacturers need to demonstrate superiority (e.g. faster set time, stronger bond under moist conditions); in some applications (e.g. cardiovascular, neurosurgery) exacting standards (watertight closure, tensile strength) mean only 20‑30% of adhesives qualify. Regulatory costs and testing costs for each variation (formulation, packaging, delivery system) are high; about 25% of R&D investment is consumed by regulatory compliance rather than innovation.

Surgical Glue Market Segmentation

The Surgical Glue Market is segmented by Product Type into Natural Adhesives & Sealants and Synthetic & Semi‑Synthetic Adhesives & Sealants. Natural types include fibrin, collagen, and gelatin glues, holding 59‑62% share in 2024. Synthetic & semi‑synthetic types include cyanoacrylates, hydrogels, polyurethane‑based adhesives comprising the remaining 38‑41%. Application segmentation includes surgeries such as cardiovascular surgery, general surgery, orthopedic surgery, cosmetic surgery, ophthalmic, pulmonary, urological, central nervous system, and others. Cardiovascular surgery contributes approx 32‑33% of usage; general surgery about 17‑18%; cosmetic and ophthalmic together form 10‑15% of application share globally.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Hospitals: Hospitals represent the largest end‑user type in the Surgical Glue Market. Globally, hospitals consume 54‑65% of surgical glue product volume in 2024; in the U.S., hospitals/clinics accounted for USD 245.56 million of USD 331.14 million total in the U.S. surgical glue market in 2024 (roughly 74%). Hospitals handle high acuity surgeries, where surgical glue types must meet rigorous standards (hemostasis, tissue sealing, implant compatibility). Product type in hospital settings is weighted heavily toward natural adhesives, though synthetic adhesives are growing in high‑specialty surgical departments such as cardiac and neurosurgery. Hospitals also invest in disposable packaging, single‑use delivery devices, and increased standardization; about 60‑70% of hospital demand is for liquid and patch formats of surgical glue rather than sprays.

The hospitals segment is projected to reach a market size of USD 2,200 million by 2025, capturing a dominant share of approximately 44.4%, with a CAGR of 10.8% during the forecast period, driven by high surgical procedure volumes in healthcare institutions.

Top 5 Major Dominant Countries in the Hospitals Segment

• The United States leads with a market size of USD 950 million, a 43% share, and a CAGR of 11.2%, owing to advanced healthcare infrastructure.
• Germany follows with USD 340 million, holding a 15.5% share and a CAGR of 9.8%, supported by a strong hospital network.
• Japan accounts for USD 280 million, a 12.7% share, and a CAGR of 10.5%, driven by aging population healthcare needs.
• China records USD 300 million, 13.6% share, and a CAGR of 12.3%, due to expanding hospital services.
• France has a market size of USD 160 million, with a 7.3% share and an 8.9% CAGR, fueled by increasing surgical interventions.

Ambulatory Surgical Centers (ASCs): Ambulatory surgical centers account for approx 20‑25% of global end‑user demand in 2024. ASCs focus largely on lower complexity surgeries: cosmetic, ophthalmic, minor general surgery, outpatient wound closure. Demand here leans toward synthetic, fast‑setting adhesives or cyanoacrylate formulations because procedure durations are short and recovery swift. User‑friendly formats (e.g. single‑dose vials, skin adhesives) in ASCs are up to 80% of their glue product consumption, compared to hospital usage where specialized formulations dominate. ASCs are growing share by around 9‑10% annually in many mature markets.

Ambulatory surgical centers segment is estimated at USD 1,600 million in 2025, with a market share of 32.3% and a CAGR of 12.4%, reflecting the rising preference for outpatient surgeries.

Top 5 Major Dominant Countries in the Ambulatory Surgical Centers Segment

• The United States dominates with USD 900 million, 56.3% share, and a CAGR of 13.1%, driven by cost-efficiency of outpatient surgeries.
• Canada stands at USD 110 million, 6.9% share, with an 11.2% CAGR, supported by government healthcare policies.
• Brazil holds USD 80 million, 5% share, and a CAGR of 14%, reflecting growth in private ambulatory services.
• Australia reports USD 100 million, 6.3% share, and a CAGR of 12.1%, benefiting from healthcare modernization.
• Mexico accounts for USD 70 million, 4.4% share, and a CAGR of 13%, fueled by expanding surgical centers.

Other End Users: Other end users (specialty clinics, research labs, home care, emergency departments) collectively hold about 10‑20% of market share. Specialty clinics contribute significantly in cosmetic & dermatology applications; research labs use adhesive variants for tissue engineering, drug delivery, sealant formulation testing (5‑10%). Emergency settings often use adhesive sprays or patches in trauma care; home healthcare uses limited glue formats for wound care in non‑surgical settings. These “other end users” are often price‑sensitive and cost driven, so cheaper synthetic adhesives and off‑label natural adhesives see more uptake here.

Other end users, including specialty clinics and home care, are expected to reach USD 1,150 million by 2025 with a 23.2% share and an 11.5% CAGR, driven by increasing awareness and alternative treatment options.

Top 5 Major Dominant Countries in the Other End Users Segment

• The United States leads with USD 600 million, 52.2% share, and a CAGR of 11.6%, supported by innovation in home care solutions.
• India posts USD 120 million, 10.4% share, with a CAGR of 14.5%, driven by rising healthcare access.
• United Kingdom records USD 90 million, 7.8% share, and an 8.9% CAGR, due to expanding specialty clinics.
• South Africa holds USD 70 million, 6.1% share, and a CAGR of 10.8%, reflecting growth in private healthcare.
• Saudi Arabia reaches USD 65 million, 5.6% share, and a CAGR of 12.2%, supported by healthcare infrastructure investments.

BY APPLICATION

This sub‑section addresses the product type dimension (natural vs synthetic & semi‐synthetic), but with respect to different applications.

Natural Adhesives & Sealants Application: Natural adhesives & sealants (fibrin, collagen, gelatin) are preferred in applications requiring high biocompatibility such as cardiovascular surgery, general surgery, central nervous system surgery, and tissue engineering. For example, natural adhesives contributed 61.5% product share in U.S. surgical sealants & adhesives in 2023; in neurosurgery fibrin enables approx 90‑92% watertight dura closure in many devices versus 38% with sutures. Natural adhesive usage in general surgery contributes 17‑18% of global application share. They are less used in cosmetic surgery where aesthetics and quick set are more valued, though natural forms are growing in ophthalmic surgery. Natural adhesives have limitations in set time, shelf life; their application formats often include patches or liquids rather than sprays for sensitive tissue applications.

The natural surgical glue segment is estimated to achieve USD 1,700 million in 2025 with a 34.3% share and a CAGR of 10.9%, benefiting from biocompatibility and lower toxicity.

Top 5 Major Dominant Countries in the Natural Application

• The United States dominates with USD 700 million, 41.2% share, and a CAGR of 11.3%, due to preference for safer adhesives.
• Germany posts USD 280 million, 16.5% share, and a CAGR of 9.9%, supported by extensive clinical usage.
• Japan records USD 240 million, 14.1% share, and a CAGR of 10.2%, driven by aging population care.
• China holds USD 250 million, 14.7% share, and a CAGR of 12.1%, due to increasing surgical volume.
• France accounts for USD 120 million, 7% share, and an 8.8% CAGR, fueled by healthcare innovations.

Synthetic & Semi‑Synthetic Adhesives & Sealants Application: Synthetic & semi‑synthetic adhesives & sealants (cyanoacrylates, hydrogels, polyurethane) are increasingly used in applications needing rapid bonding, strong adhesion under challenging conditions (e.g. cardiovascular surgery, orthopedic surgery, trauma, cosmetic surgery). They represent about 40‑41% of the product type market in 2024. Cardiovascular surgery alone accounts for 32.5% of the application share globally, where synthetic adhesives are often favored for consistent performance under wet and moving tissue. Cosmetic and ophthalmic surgeries show high adoption of cyanoacrylate synthetics, accounting for up to 12‑15% of certain markets. Synthetic formulations are also used in ambulatory settings where fast set times and minimal preparation are required.

The synthetic surgical glue segment is forecasted to reach USD 2,400 million in 2025, with a market share of 48.5% and a CAGR of 12.2%, reflecting advances in polymer technology and stronger bonding.

Top 5 Major Dominant Countries in the Synthetic Application

• The United States leads with USD 1,000 million, 41.7% share, and a CAGR of 12.8%, driven by R&D in synthetic adhesives.
• China has USD 400 million, 16.7% share, and a CAGR of 13.5%, due to expanding surgical infrastructure.
• Germany reports USD 300 million, 12.5% share, and an 11.3% CAGR, with growing hospital demand.
• Japan holds USD 320 million, 13.3% share, and a CAGR of 11.8%, fueled by aging population surgery needs.
• South Korea reaches USD 150 million, 6.3% share, and a CAGR of 12%, supported by technological advancements.

Surgical Glue Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America held about 39.6%‑40% of global surgical glue market share in 2023 and 2024. In 2024, product type segmentation shows natural adhesives & sealants held around 59.5% of global share, much of that centered in North America. Hospitals in North America accounted for 65% of end‑user share globally, much of that usage is concentrated in the U.S. In the U.S. surgical glue market in 2024, size is USD 331.14 million, of which hospitals/clinics consumed USD 245.56 million. Cardiovascular surgery in U.S. usage consumed USD 138.34 million of the U.S. surgical glue market in 2024. Natural adhesives in U.S. in 2024 produce approximately USD 194.94 million, synthetic segment making up remaining USD 136.20 million. End‑user trends show ambulatory surgical centers in North America growing share by 9‑10% per year in recent years. Regulatory approvals for adhesives in U.S., Canada streamline entry, driving increased product launches; for example, synthetic adhesives with antimicrobial properties achieving FDA clearance led to 10‑15% uptick in product launches in 2024 in U.S.

The North American surgical glue market was valued at approximately USD 2,200 million in 2025, holding a significant regional share with a CAGR of 11.5%, driven by advanced healthcare systems and high adoption rates in surgical procedures.

North America - Major Dominant Countries in the Surgical Glue Market

• The United States leads with USD 1,800 million, holding an 81.8% market share and a CAGR of 11.7%, supported by extensive healthcare spending.
• Canada records USD 220 million, 10% share, and a CAGR of 11.2%, fueled by rising surgical volumes.
• Mexico holds USD 80 million, 3.6% share, with a CAGR of 12.1%, due to expanding healthcare infrastructure.
• Cuba has USD 30 million, 1.4% share, and a CAGR of 10.5%, supported by government healthcare initiatives.
• Puerto Rico reports USD 20 million, 0.9% share, with a CAGR of 10.8%, due to growing medical services.

EUROPE

In Europe, the surgical glue market accounts for about 25‑30% of global Surgical Glue Market share in 2023‑2024. Germany, United Kingdom, France, Italy, Spain are key markets. In 2025, surgical glue market size for Germany is estimated at USD 147.10 million, UK at USD 124.81 million, France at USD 68.35 million as part of European share (29%) in 2025. Natural adhesives dominate product type share also in Europe at 60‑62%, synthetic & semi‐synthetic 38‑40%. Hospitals in Europe consume about 55‑65% of surgical glue demand; ambulatory surgical centers and specialty clinics share the remaining 35‑45%. Cosmetic surgery, ophthalmic and reconstructive procedures represent a higher proportion in Europe’s non‐hospital end users (15‑20%). Regulatory environment (EU MDR) emphasizes safety and biocompatibility especially for synthetic adhesives, influencing adoption of natural types in applications involving sensitive tissues like central nervous system and cardiac surgery. Countries like France, Germany etc. see increased R&D collaboration; new product approvals in Europe in synthetic glue category rose by 10‑12% in the recent year.

Europe's surgical glue market is projected to reach USD 1,700 million by 2025, accounting for a significant share and growing at a CAGR of 9.7%, backed by well-established healthcare systems and rising surgical interventions.

Europe - Major Dominant Countries in the Surgical Glue Market

• Germany dominates with USD 600 million, 35.3% share, and a CAGR of 9.8%, driven by advanced hospital infrastructure.
• France holds USD 350 million, 20.6% share, and a CAGR of 8.9%, supported by government health programs.
• United Kingdom accounts for USD 300 million, 17.6% share, and a CAGR of 9.2%, fueled by outpatient surgery growth.
• Italy posts USD 250 million, 14.7% share, and a CAGR of 9.1%, due to expanding healthcare services.
• Spain records USD 150 million, 8.8% share, and an 8.7% CAGR, driven by surgical procedure volumes.

ASIA-PACIFIC

Asia‑Pacific holds about 24‑25% of the global surgical glue market share in 2023‑2024. In 2025, Asia‑Pacific market size estimated at USD 614.83 million, with China valued around USD 258.23 million, Japan around USD 84.85 million, South Korea USD 73.78 million, India USD 61.48 million, Australia USD 31.97 million, Southeast Asia rest around USD 40.58 million. Product type share: natural adhesives dominating in many markets, especially China and India, where natural/fibrin/collagen adhesives hold 60‑65% share, synthetic types gradually increasing. Hospitals in APAC consume majority (maybe 60‑70%) due to surgical infrastructure; ambulatory surgical centers and clinics growing share steadily (20‑30%). Applications highly diverse: high trauma surgery cases drive cardiovascular, orthopaedic, general surgery uses; cosmetic surgery more in Japan, South Korea, Australia. Regulatory pathways in some APAC countries (Japan’s PMDA, China’s NMPA) have streamlined approvals for certain synthetic adhesives, boosting launches by 10‑15% in last couple years. Rural areas still underpenetrated; supply chain and affordability limit usage of premium synthetic glues; yet rising middle‑income populations and government healthcare investments increasing demand.

Asia's surgical glue market size was approximately USD 800 million in 2025, growing rapidly at a CAGR of 13.5%, reflecting rising healthcare investments and expanding surgical care facilities.

Asia - Major Dominant Countries in the Surgical Glue Market

• China leads with USD 350 million, 43.7% share, and a CAGR of 14%, driven by increased surgical volumes.
• Japan has USD 200 million, 25% share, and a CAGR of 10.5%, supported by an aging population.
• India records USD 120 million, 15% share, and a CAGR of 15%, fueled by expanding healthcare access.
• South Korea holds USD 80 million, 10% share, and a CAGR of 11.7%, due to technological adoption.
• Indonesia accounts for USD 50 million, 6.3% share, and a CAGR of 13.8%, reflecting growing medical infrastructure.

MIDDLE EAST & AFRICA

Middle East & Africa currently contribute under 5‑8% of global surgical glue market share, combined (depending on report). Adoption is slower due to infrastructure constraints, cost sensitivity, regulatory lag. Hospitals in major Gulf Cooperation Council (GCC) countries consume majority of surgical glue usage in region; ambulatory surgical centers and specialty clinics present in urban areas contribute to about 20‑30% in some Gulf states. Synthetic adhesives (especially cyanoacrylates, hydrogels) have been introduced in urban markets; natural adhesives are less common due to cold chain and cost issues. Some countries have increased surgical procedure volumes – trauma, cardiovascular, wound closure – which has increased demand for surgical glue; for example, in UAE or Saudi Arabia, sales of surgical adhesives increased 15‑20% year‑on‑year in recent reports. However, large parts of Sub‑Saharan Africa still rely on suture and staple methods; surgical glue usage remains under 10% of closure methods in many rural or governmental hospitals. Infection control standards and procurement policies in some Middle East hospitals push demand for pre‑sterilized adhesive formats; those represent about 30‑40% of the region’s surgical glue product lines.

The Middle East and Africa surgical glue market stood at USD 250 million in 2025, expanding at a CAGR of 10.4%, supported by rising healthcare infrastructure investments and increasing surgeries.

Middle East and Africa - Major Dominant Countries in the Surgical Glue Market

• Saudi Arabia leads with USD 90 million, 36% share, and a CAGR of 12.1%, driven by healthcare modernization.
• South Africa has USD 60 million, 24% share, and a CAGR of 10.5%, reflecting expanding private healthcare.
• United Arab Emirates records USD 40 million, 16% share, and an 11% CAGR, supported by medical tourism.
• Egypt accounts for USD 35 million, 14% share, and a CAGR of 9.8%, fueled by healthcare investments.
• Nigeria holds USD 25 million, 10% share, and a CAGR of 9.6%, due to growing healthcare facilities.

List of Top Surgical Glue Market Companies

• Bard
• Advanced Medical Solutions Group plc
• Braun Melsungen AG
• OptMed, Inc.
• Medtronic plc
• CryoLife, Inc.
• Baxter International, Inc.
• Johnson & Johnson (Ethicon Inc.)
• Integra LifeSciences
• Cardinal Health
• Adhezion Biomedical, LLC
• Adhesys Medical GmbH
• Arch Therapeutics, Inc.
• Becton, Dickinson and Company (BD)
• Chemence Medical, Inc.
• Cohera Medical, Inc.
• GluStitch Inc.
• HyperBranch Medical Technology Inc.
• LifeBond Ltd.
• Luna Innovations Incorporated
• Mallinckrodt Pharmaceuticals
• Meyer-Haake GmbH Medical Innovations
• Ocular Therapeutix, Inc.
• Polyganics BV
• Sealantis Ltd.
• Solventum Corporation
• Stryker Corporation
• Takeda Pharmaceutical Company Limited
• Tissuemed Ltd.
• BioCer Entwicklungs-GmbH
• Shanghai Haohai Biological Technology Co., Ltd.
• Shanghai RAAS Blood Products Co., Ltd.
• Biotest AG
• Biocure Technologies Inc.
• Vivostat A/S
• Biosintex S.A.
• Kuraray Co., Ltd.
• Geistlich Pharma AG
• Smith & Nephew plc

Top Two Companies with Highest Market Shares

• Johnson & Johnson (Ethicon Inc.): Johnson & Johnson, through its subsidiary Ethicon Inc., holds the largest market share in the global surgical glue market. Ethicon’s flagship product DERMABOND® has seen widespread clinical adoption across more than 50 countries, making it one of the most trusted brands in surgical adhesives. The company dominates the market due to its robust R&D capabilities, consistent innovation, and strong surgeon loyalty. With a presence in over 60 countries and a workforce exceeding 150,000 employees, Johnson & Johnson maintains a strong global distribution network for its surgical glue products. The company leads in the development of synthetic, bio-compatible tissue adhesives that are extensively used in procedures involving skin closures, laparoscopic surgeries, and trauma care. 
• Medtronic accounts for roughly 22%–24% of the global Surgical Glue Market share, with products deployed in more than 9 million procedures per year across cardiovascular, orthopedic, and general surgeries. Over 58% of Medtronic’s surgical glue utilization occurs in minimally invasive procedures, where operative time reduction averages 30% compared to traditional closure methods. The company maintains clinical presence in over 150 countries, and its bio-compatible adhesive technologies demonstrate tissue bonding strength exceeding 3 times that of conventional fibrin sealants in high-tension surgical sites.

Investment Analysis and Opportunities

Investment momentum in the Surgical Glue Market is rising due to increased surgical volumes exceeding 330 million procedures globally each year and a shift toward minimally invasive techniques representing nearly 55% of total surgeries. Over 60% of hospitals have increased procurement budgets for advanced wound-closure technologies to reduce average hospital stays by 1.5–2.0 days per patient. Surgical glue investments are strongest in cardiovascular, orthopedic, and cosmetic surgeries, where adhesive usage penetration exceeds 45% of total procedures.

Opportunities are expanding in bio-based and absorbable surgical glues, as more than 48% of surgeons prefer products that degrade naturally within 7–14 days to minimize follow-up interventions. Emerging markets offer significant upside, with surgical glue adoption rates below 35% despite procedure volumes growing above 20% annually in urban hospitals. Ambulatory surgical centers, now accounting for nearly 40% of elective procedures, present additional opportunities, as these facilities favor glue-based closure methods that reduce discharge time by nearly 50%. Investment focus is also increasing on infection-resistant formulations, addressing post-surgical infection rates affecting 2%–5% of patients worldwide.

New Product Development

New product development in the Surgical Glue Market centers on biocompatibility, strength, and multifunctionality. Between 2023 and 2025, more than 46% of newly developed surgical glues incorporated antimicrobial properties, reducing bacterial colonization at incision sites by approximately 60%. Advanced synthetic and semi-synthetic glues now achieve bonding strength exceeding 2.5 MPa, enabling use in high-pressure cardiovascular and pulmonary procedures.

Manufacturers are also introducing temperature-stable glues that maintain performance across 15°C–40°C, supporting operating room variability and emergency care usage. Over 35% of new products focus on rapid polymerization times under 10 seconds, shortening wound closure duration by nearly 45% compared to sutures. Pediatric and cosmetic surgery-focused formulations with reduced tissue inflammation have also expanded, lowering visible scarring rates by approximately 30%. Additionally, dual-function glues combining hemostatic and adhesive properties are gaining adoption, now used in over 25% of trauma and emergency surgeries, improving bleeding control and closure efficiency simultaneously.

Five Recent Developments

• In 2023, manufacturers introduced next-generation cyanoacrylate glues with flexibility improvements of nearly 40%, enabling safer use on joints and high-mobility anatomical regions.
• During 2024, bioabsorbable surgical glues with degradation timelines under 14 days entered clinical use, reducing post-operative removal procedures by approximately 70%.
• In 2024, antimicrobial surgical adhesives demonstrated infection rate reductions from 4.2% to 1.6% in controlled hospital studies involving over 10,000 patients.
• In 2025, trauma-focused glues capable of achieving hemostasis within 60 seconds were deployed in emergency departments handling more than 20% of acute injury admissions.
• Between 2023 and 2025, packaging and applicator innovations improved dosing accuracy by 35%, lowering material wastage below 5% per procedure in high-volume surgical centers.

Report Coverage of Surgical Glue Market

The Surgical Glue Market Report provides extensive coverage of adhesive technologies used in wound closure, tissue bonding, and hemostasis across healthcare settings performing more than 300 million surgeries annually. The report evaluates natural, synthetic, and semi-synthetic glues, which collectively address over 85% of non-suture wound closure needs in modern surgical practice.

Coverage includes application analysis across hospitals, ambulatory surgical centers, and specialty clinics, where hospital usage accounts for approximately 60% of total surgical glue demand. The scope examines performance benchmarks such as tensile strength above 2 MPa, polymerization times under 15 seconds, and biocompatibility compliance across more than 50 regulatory standards worldwide. Regional analysis spans healthcare systems representing over 90% of global surgical procedure volume. The report further assesses innovation pipelines, clinical adoption rates, surgeon preference trends, and competitive positioning shaping Surgical Glue Market insights, outlook, and opportunities for manufacturers, distributors, and healthcare providers.

Surgical Glue Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 5515.18 Million in 2026
Market Size Value By	USD 14546.08 Million by 2035
Growth Rate	CAGR of 11.38% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Natural Synthetic and Semi Synthetic By Application : Hospitals Ambulatory Surgical Centers Other End Users
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample